학술논문

Phase I-II study to evaluate safety and efficacy of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial): Preliminary data of phase I study.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 20 2022, 40 6, 3p. Supplement: S
Subject
Language
English
ISSN
15277755